Analytic Core (Core D)
分析核心(核心 D)
基本信息
- 批准号:10541805
- 负责人:
- 金额:$ 28.79万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-07-15 至 2025-12-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAlzheimer&aposs DiseaseAmyloidBiological MarkersBiometryBrainBrain PathologyClinicalClinical DataClinical TrialsClinical Trials DesignCognitiveCommunitiesComplexConsultationsCustomDataData AdjustmentsData AnalysesData ElementData SecurityData SetData Storage and RetrievalDatabase Management SystemsDatabasesDementiaDerivation procedureDevelopmentDiseaseDropsEnsureEpidemiologic MethodsEventEvolutionFutureGeneticGrowthImageImpaired cognitionInformation SystemsInterventionJointsKnowledgeMeasurementMeasuresMediationMethodsModelingModernizationParticipantPathologyPopulationPrevention trialProceduresProcessQuality ControlResearch DesignRiskSample SizeSamplingSecureSecuritySelection BiasSourceStatistical Data InterpretationStatistical MethodsStatistical ModelsSystemTestingTimeTranslationsWorkaging brainanalytical methodcognitive performancedata accessdata de-identificationdata integrationdata integritydata managementdata sharingdesigndigital assessmentflexibilityfollow-upformycin triphosphateimaging modalityimprovedinnovationlongitudinal analysisneuroimagingpre-clinicalpreventprogramsquality assurancequery optimizationsimulationstudy populationtau Proteinstool
项目摘要
SUMMARY: CORE D- ANALYTIC CORE. The rigorous integration, analysis and interpretation of a wide array
of data from the Cores and Projects is central to the Harvard Aging Brain Study (HABS). The Data Core
provides the database and statistical support for these functions. The Core has developed and optimized: (i)
the DataCentral database for data entry, quality assurance, storage, backup, security, and query systems, as
well as linkage to raw and processed image files, (ii) data distribution for biostatistical analyses to support the
project aims, and (iii) blinding to prevent inadvertent bias. The Core also supports, designs, and implements
analyses that contribute to the definition and quantification of critical disease pathologies, brain networks,
biomarkers, and their interactions, and participates in the selection of subsets of the sample for additional
procedures or specific analyses, as needed. We also develop summary measures of brain pathologies and
network disruption that can be used in a wide variety of analyses within and across projects, address methods
needed for time-to-event and longitudinal analyses across multiple nonlinear processes within the aging brain,
and develop models to address questions of causal inference. The Specific Aims of the Data Core are: 1. Data
Integrity and Integration, which includes data entry, quality control, and storage; data access and distribution;
and data sharing; 2. Statistical Support, Oversight, and Analysis, which involves statistical support for the
Projects and Cores including simulation-guided study design and data analysis, and use of modern
epidemiologic methods in causal inference to inform model construction, mediation analyses, and adjustment
for selection bias and confounding, and 3. Development of Innovative Statistical Models and Methods, which
includes joint modeling of PiB, FTP, functional connectivity and cognitive measures; treatment of misaligned
biomarker measurements; modeling of censored time-to-event data that adjusts for delayed entry; derivation of
efficient prevention trial populations and endpoints; and development of new methods for adjusting for
selection bias in the setting of change-in-change analyses. Overall, the overarching responsibilities of the Data
Core are to: manage the large and complex array of data that continues to be collected in the project, including
neuroimaging data, clinical data, genetic, and biofluid data; integrate all data elements into a single database;
and oversee and facilitate the statistical analyses for each Project--and across projects--using optimal analytic
methods. Analytic Core support will ensure that the Program Project achieves unbiased and robust results that
improve understanding of the course of Alzheimer’s disease and its translation into future efficient clinical
trials.
摘要:核心D-分析核心。
来自核心和核心的数据是哈佛大学脑研究(HAB)的核心
为功能提供数据库和统计支持。
用于数据输入,质量分配,存储,备份,安全性和查询系统的数据中心数据库,
以及与原始图像文件的链接,(ii)生物统计分析的数据分布,以支持
项目的目的,(iii)对预防的无意偏见也支持,设计和工具
有助于关键疾病病理,大脑网络的定义和量化的分析
生物标志物及其相互作用,并参与样本子集的选择以获取附加
程序或特定的分析,我们还制定了脑部病理的摘要措施
可以在项目内部和跨项目内的各种分析中使用的网络中断,解决方法
在衰老大脑内的多个非层非线性过程中,需要花费时间和纵向的时间和纵向
并开发用于解决因果推理的问题的模型。
完整性和集成,包括数据输入,质量控制和存储;
和数据共享;统计支持,监督和分析
项目和核心包括模拟引入的研究设计和数据分析以及现代的使用
因果关系中的流行病学方法,以告知模型限制,中性分析和调整
用于选择偏见和混杂,以及3。创新统计模型和方法的开发,
包括PIB的联合建模,FTP,功能连接和认知措施;
生物标志物测量
预防效率试验和终点;
在变更分析的设置中的选择偏差。
核心是:管理继续在项目中收集的大型且复杂的数据阵列,包括
神经影像学数据,临床数据,遗传和生物流体数据;
并使用最佳分析来监督和促进每个项目以及整个项目的统计分析
方法。
提高对阿尔茨海默氏病进程的理解,并且是翻译的ITS INTE INTIC FUTURE效率临床
试验。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Deborah L. BLACKER其他文献
Deborah L. BLACKER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Deborah L. BLACKER', 18)}}的其他基金
Small vessel disease and beta-amyloid deposition in mildly impaired cognition
轻度认知障碍中的小血管疾病和 β-淀粉样蛋白沉积
- 批准号:
8223287 - 财政年份:2008
- 资助金额:
$ 28.79万 - 项目类别:
Small vessel disease and beta-amyloid deposition in mildly impaired cognition
轻度认知障碍中的小血管疾病和 β-淀粉样蛋白沉积
- 批准号:
8037151 - 财政年份:2008
- 资助金额:
$ 28.79万 - 项目类别:
GENETIC KNOWLEDGE AND ATTITUDES IN ALZHEIMER'S DISEASE
阿尔茨海默病的遗传知识和态度
- 批准号:
2861531 - 财政年份:1999
- 资助金额:
$ 28.79万 - 项目类别:
GENETIC KNOWLEDGE AND ATTITUDES IN ALZHEIMER'S DISEASE
阿尔茨海默病的遗传知识和态度
- 批准号:
6181644 - 财政年份:1999
- 资助金额:
$ 28.79万 - 项目类别:
GENETIC KNOWLEDGE AND ATTITUDES IN ALZHEIMER'S DISEASE
阿尔茨海默病的遗传知识和态度
- 批准号:
6388318 - 财政年份:1999
- 资助金额:
$ 28.79万 - 项目类别:
DEFINING CASENESS FOR PSYCHIATRIC LINKAGE STUDIES
定义精神病学关联研究的案例
- 批准号:
2240547 - 财政年份:1993
- 资助金额:
$ 28.79万 - 项目类别:
DEFINING CASENESS FOR PSYCHIATRIC LINKAGE STUDIES
定义精神病学关联研究的案例
- 批准号:
2240549 - 财政年份:1993
- 资助金额:
$ 28.79万 - 项目类别:
DEFINING CASENESS FOR PSYCHIATRIC LINKAGE STUDIES
定义精神病学关联研究的案例
- 批准号:
2430887 - 财政年份:1993
- 资助金额:
$ 28.79万 - 项目类别:
相似国自然基金
基于神经退行性疾病前瞻性队列的新烟碱类杀虫剂暴露对阿尔茨海默病的影响及作用机制研究
- 批准号:
- 批准年份:2022
- 资助金额:53 万元
- 项目类别:面上项目
基于miRNA介导ceRNA网络调控作用的防治阿尔茨海默病及认知障碍相关疾病药物的发现研究
- 批准号:
- 批准年份:2020
- 资助金额:55 万元
- 项目类别:面上项目
LMTK1调控核内体转运介导阿尔茨海默病神经元Reserve机制研究
- 批准号:81903703
- 批准年份:2019
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
基于自组装多肽纳米探针检测蛋白标志物用于阿尔茨海默病精准诊断的研究
- 批准号:31900984
- 批准年份:2019
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
靶向干预CD33/Aβ相互作用改善小胶质细胞功能延缓AD病理进程
- 批准号:81901072
- 批准年份:2019
- 资助金额:20.5 万元
- 项目类别:青年科学基金项目
相似海外基金
Uncovering Mechanisms of Racial Inequalities in ADRD: Psychosocial Risk and Resilience Factors for White Matter Integrity
揭示 ADRD 中种族不平等的机制:心理社会风险和白质完整性的弹性因素
- 批准号:
10676358 - 财政年份:2024
- 资助金额:
$ 28.79万 - 项目类别:
The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
- 批准号:
10749539 - 财政年份:2024
- 资助金额:
$ 28.79万 - 项目类别:
Fluency from Flesh to Filament: Collation, Representation, and Analysis of Multi-Scale Neuroimaging data to Characterize and Diagnose Alzheimer's Disease
从肉体到细丝的流畅性:多尺度神经影像数据的整理、表示和分析,以表征和诊断阿尔茨海默病
- 批准号:
10462257 - 财政年份:2023
- 资助金额:
$ 28.79万 - 项目类别: